Mass spectrometry‐based metabolomics: applications to biomarker and metabolic pathway research
Citations Over TimeTop 10% of 2015 papers
Abstract
Mass spectrometry-based metabolomics has become increasingly popular in molecular medicine. High-definition mass spectrometry (MS), coupled with pattern recognition methods, have been carried out to obtain comprehensive metabolite profiling and metabolic pathway of large biological datasets. This sets the scene for a new and powerful diagnostic approach. Analysis of the key metabolites in body fluids has become an important part of improving disease diagnosis. With technological advances in analytical techniques, the ability to measure low-molecular-weight metabolites in bio-samples provides a powerful platform for identifying metabolites that are uniquely correlated with a specific human disease. MS-based metabolomics can lead to enhanced understanding of disease mechanisms and to new diagnostic markers and has a strong potential to contribute to improving early diagnosis of diseases. This review will highlight the importance and benefit with certain characteristic examples of MS-metabolomics for identifying metabolic pathways and metabolites that accurately screen for potential diagnostic biomarkers of diseases.
Related Papers
- → Recent Advances in Capillary Electrophoresis-Based Proteomic Techniques for Biomarker Discovery(2013)13 cited
- → Biomarker Discovery in Biological Fluids(2011)5 cited
- → Surface-Enhanced Laser Desorption/Ionization Mass Spectrometry for Protein and Peptide Profiling of Body Fluids(2008)8 cited
- → Use of high-throughput LC–MS/MS proteomics technologies in drug discovery(2006)6 cited
- → LIPIDS | Determination in Biological Fluids(2013)